Figure 9. Study model.
(A) The mechanism for DPAGT1-induced HER2 shedding and trastuzumab resistance in HER2+ breast cancer. (B) Targeting DPAGT1 might be as a promising strategy to prevent or overcome trastuzumab resistance in HER2+ breast cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.